Zimmer Holdings, Inc. (ZMH) Upgraded by Lazard Capital to “Buy”

Equities research analysts at Lazard Capital upgraded shares of Zimmer Holdings, Inc. (NYSE: ZMH) from a “neutral” rating to a “buy” rating in a research note to investors on Friday.

Separately, analysts at Standpoint Research downgraded shares of Zimmer Holdings, Inc. from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, April 27th. Also, analysts at WellsFargo & Co. (NYSE: WFC) initiated coverage on shares of Zimmer Holdings, Inc. in a research note to investors on Tuesday, March 29th. They set an “outperform” rating on the stock.

Shares of Zimmer Holdings, Inc. opened at 65.25 on Monday. Zimmer Holdings, Inc. has a 52 week low of $46.27 and a 52 week high of $66.75. The stock’s 50-day moving average is $61.18 and its 200-day movingaverage is $56.39. The company has a market cap of $12.536 billion and a price-to-earnings ratio of 21.97.

Zimmer Holdings, Inc. last announced its quarterly results on Thursday, April 28th. The company reported $1.19 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $1.12 EPS by $0.07. During the same quarter in the prior year, the company posted $1.02 earnings per share. The company’s quarterly revenue was up 5.00% on a year-over-year basis. On average, analysts predict that Zimmer Holdings, Inc. will post $1.07 EPS next quarter.

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive implants, dental implants, spinal implants, trauma products and related surgical products. It also provides other healthcare related services. The Company’s primary customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons. It has operations in more than 25 countries and market products in more than 100 countries. The Company manages its operations through three geographic segments: the Americas, Europe and Asia Pacific.

Stay on top of analysts’ coverage with American Banking & Market News’ daily email newsletter that provides a concise list of analysts’ upgrades, analysts’ downgrades and analysts’ price target changes for each day.Click here to register.



Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets